| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/1998 | EP0817779A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/14/1998 | EP0817778A1 Reversible protease inhibitors |
| 01/14/1998 | EP0817775A1 Quinazoline derivatives |
| 01/14/1998 | EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817769A1 Novel borneol esters, process for their preparation and their pharmaceutical use |
| 01/14/1998 | EP0817767A1 Bicyclic amine derivatives and their use as anti-psychotic agents |
| 01/14/1998 | EP0817645A1 Method for treatment of benign prostatic hypertrophy |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0817641A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 01/14/1998 | EP0817636A1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
| 01/14/1998 | EP0817635A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 01/14/1998 | EP0817634A1 Azathioprine compositions for colonic administration |
| 01/14/1998 | EP0817633A1 Transdermal device for the delivery of alfuzosin |
| 01/14/1998 | EP0817632A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/14/1998 | EP0817631A2 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| 01/14/1998 | EP0817630A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817629A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817626A2 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 01/14/1998 | EP0817625A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/14/1998 | EP0817624A1 Inhibitors of metazoan parasite proteases |
| 01/14/1998 | EP0817623A1 Medicaments for the selective treatment of tumour tissues |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0817621A1 Pharmaceutical composition for transdermic delivery |
| 01/14/1998 | EP0817618A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 01/14/1998 | EP0817615A2 Peroral composition for controlled release in the lower gastrointestinal tract |
| 01/14/1998 | EP0817612A1 Transparent rapid-release preparations of non-steroid analgesics |
| 01/14/1998 | EP0817611A1 Butixocort aerosol formulations |
| 01/14/1998 | EP0817610A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it |
| 01/14/1998 | EP0719278B1 Androstenone derivative |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0684825A4 Method of preventing or inhibiting fertilization. |
| 01/14/1998 | EP0674639B1 Azanoradamantanes |
| 01/14/1998 | EP0662950B1 Benzenealkanoic acids for cardiovascular diseases |
| 01/14/1998 | EP0660832B1 Serotonin receptor agents |
| 01/14/1998 | EP0655060B1 Pharmaceutically active diketopiperazines |
| 01/14/1998 | EP0652890B1 Oligonucleotide alkylphosphonothioates |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0642336B1 Use of nsiad in the treatment of dementia |
| 01/14/1998 | EP0603301B1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 01/14/1998 | EP0565732B1 Benzodioxane derivative |
| 01/14/1998 | EP0480052B1 Quinoline derivative, antiulcer drug containing the same, and production of said derivative |
| 01/14/1998 | CN1170435A Regulation of neural stem cell proliferation |
| 01/14/1998 | CN1170412A Suger modified nucleosides and their use for synthesis of oligonucleotides |
| 01/14/1998 | CN1170411A Quinoline derivative |
| 01/14/1998 | CN1170408A 2-carbamoyl-1, 4, 5, 6,-tetrahydropyrazines |
| 01/14/1998 | CN1170407A Sulfonamides |
| 01/14/1998 | CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists |
| 01/14/1998 | CN1170402A Nitro-benzamides useful as anti-arrhythmic agents |
| 01/14/1998 | CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 01/14/1998 | CN1170366A Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 01/14/1998 | CN1170365A Use of £R-(Z)|-alpha-(methoxyimino)-alpha-£1-azabicyclw £2. 2. 2| oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimers disease |
| 01/14/1998 | CN1170364A Liposome eye drops |
| 01/14/1998 | CN1170363A Remedy for ischemic diseases |
| 01/14/1998 | CN1170362A Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 01/14/1998 | CN1170359A Transdermal system for the simultaneous delivery of a number of active principles |
| 01/14/1998 | CN1170358A Chewable dosage forms |
| 01/14/1998 | CN1170353A Intravaginal drug delivery devices for the administration fo 17 'beta'-oestradiol precursors |
| 01/14/1998 | CN1170340A Silicone compositions |
| 01/14/1998 | CN1169995A Process for preparation of 5-(alkoxymethyl)-2, 3-pyridinedicarboximide compounds |
| 01/14/1998 | CN1169994A Xanthine compounds having terminally aminated alkynol side chains |
| 01/14/1998 | CN1169993A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 01/14/1998 | CN1169992A Sulfur-containing heterocyclic brad-ykinin antagcnists, process for their preparation and their use |
| 01/14/1998 | CN1169987A Ortho-substituen benzoyl guanidine, its preparation, use and mecdicines containing it |
| 01/14/1998 | CN1169986A 2.9-diamino-and 2-amino-8-carbamoyl-4-hydroxy-aldanoic acid amide derivatives |
| 01/14/1998 | CN1169864A Medicine for cough and asthma |
| 01/14/1998 | CN1169859A Medicine for toothache |
| 01/14/1998 | CN1169857A Active composition for relaxing intraocular pressure |
| 01/14/1998 | CN1169856A Dual alcohol injection |
| 01/14/1998 | CN1036996C Preparation of £1R-oxo-3S-thiolanylthio (thiocarbonyl)-thio|-2-azetidinones |
| 01/14/1998 | CN1036995C Imidazodiazepine, and its preparation and use |
| 01/14/1998 | CN1036993C Method for preparation aromatase inhigiting 4(5)-imidazoles |
| 01/13/1998 | US5708177 Process for the preparation of optically active ortho-substituted 4-aryl-dihydropyridines |
| 01/13/1998 | US5708174 Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
| 01/13/1998 | US5708173 Heterocyclic compounds |
| 01/13/1998 | US5708171 Imidazole derivatives for pharmaceutical use |
| 01/13/1998 | US5708169 5-amidomethyl α,β-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents |
| 01/13/1998 | US5708164 Cephalostatin analogues |
| 01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| 01/13/1998 | US5708146 Antibodies and drugs |
| 01/13/1998 | US5708038 Method of using aloe vera as a biological vehicle |
| 01/13/1998 | US5708037 Inhibitor of inflammatory cytokine formation comprising polyprenyl derivatives as the active ingredient |
| 01/13/1998 | US5708036 Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol |
| 01/13/1998 | US5708035 Methods of use and compositions of R(-) fluoxetine |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708033 Antiinflammatory agents, antiarthritic agents or analgesics |
| 01/13/1998 | US5708031 Prostaglandin E2 treatment of impotence |
| 01/13/1998 | US5708030 Substituted kynurenines and process for their preparation |
| 01/13/1998 | US5708029 High blood pressure relief method and compositions |
| 01/13/1998 | US5708028 Use of Cis-9-heptadecenoic acid for treating psoriasis and allergies |
| 01/13/1998 | US5708026 Cyclohexane derivatives |
| 01/13/1998 | US5708025 By inducing production of fetal hemoglobins by administering specified aryl acids, derivatives, salts |
| 01/13/1998 | US5708024 Salts of 2- (2,6-dichlorophenyl)amine!phenylacetoxyacetic acid with organic basic cations |
| 01/13/1998 | US5708023 Nonirritating gel for skin |
| 01/13/1998 | US5708021 Debittered ranitidine preparation |